Serveur d'exploration COVID et hydrochloroquine

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Controversies over hydroxychloroquine in the prevention of SARS-CoV-2 infection put rheumatologists on the frontline.

Identifieur interne : 000973 ( Main/Corpus ); précédent : 000972; suivant : 000974

Controversies over hydroxychloroquine in the prevention of SARS-CoV-2 infection put rheumatologists on the frontline.

Auteurs : Serena Bugatti ; Ludovico De Stefano ; Francesca Bobbio-Pallavicini ; Carlomaurizio Montecucco

Source :

RBID : pubmed:33087414

English descriptors


DOI: 10.1136/rmdopen-2020-001323
PubMed: 33087414
PubMed Central: PMC7722363

Links to Exploration step

pubmed:33087414

Le document en format XML

<record>
<TEI>
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">Controversies over hydroxychloroquine in the prevention of SARS-CoV-2 infection put rheumatologists on the frontline.</title>
<author>
<name sortKey="Bugatti, Serena" sort="Bugatti, Serena" uniqKey="Bugatti S" first="Serena" last="Bugatti">Serena Bugatti</name>
<affiliation>
<nlm:affiliation>Division of Rheumatology, IRCCS Policlinico San Matteo Foundation, Pavia, Italy serena.bugatti@unipv.it.</nlm:affiliation>
</affiliation>
<affiliation>
<nlm:affiliation>Department of Internal Medicine and Therapeutics, University of Pavia, Pavia, Italy.</nlm:affiliation>
</affiliation>
</author>
<author>
<name sortKey="De Stefano, Ludovico" sort="De Stefano, Ludovico" uniqKey="De Stefano L" first="Ludovico" last="De Stefano">Ludovico De Stefano</name>
<affiliation>
<nlm:affiliation>Division of Rheumatology, IRCCS Policlinico San Matteo Foundation, Pavia, Italy.</nlm:affiliation>
</affiliation>
<affiliation>
<nlm:affiliation>Department of Internal Medicine and Therapeutics, University of Pavia, Pavia, Italy.</nlm:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Bobbio Pallavicini, Francesca" sort="Bobbio Pallavicini, Francesca" uniqKey="Bobbio Pallavicini F" first="Francesca" last="Bobbio-Pallavicini">Francesca Bobbio-Pallavicini</name>
<affiliation>
<nlm:affiliation>Division of Rheumatology, IRCCS Policlinico San Matteo Foundation, Pavia, Italy.</nlm:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Montecucco, Carlomaurizio" sort="Montecucco, Carlomaurizio" uniqKey="Montecucco C" first="Carlomaurizio" last="Montecucco">Carlomaurizio Montecucco</name>
<affiliation>
<nlm:affiliation>Division of Rheumatology, IRCCS Policlinico San Matteo Foundation, Pavia, Italy.</nlm:affiliation>
</affiliation>
<affiliation>
<nlm:affiliation>Department of Internal Medicine and Therapeutics, University of Pavia, Pavia, Italy.</nlm:affiliation>
</affiliation>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">PubMed</idno>
<date when="2020">2020</date>
<idno type="RBID">pubmed:33087414</idno>
<idno type="pmid">33087414</idno>
<idno type="doi">10.1136/rmdopen-2020-001323</idno>
<idno type="pmc">PMC7722363</idno>
<idno type="wicri:Area/Main/Corpus">000973</idno>
<idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Corpus" wicri:corpus="PubMed">000973</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title xml:lang="en">Controversies over hydroxychloroquine in the prevention of SARS-CoV-2 infection put rheumatologists on the frontline.</title>
<author>
<name sortKey="Bugatti, Serena" sort="Bugatti, Serena" uniqKey="Bugatti S" first="Serena" last="Bugatti">Serena Bugatti</name>
<affiliation>
<nlm:affiliation>Division of Rheumatology, IRCCS Policlinico San Matteo Foundation, Pavia, Italy serena.bugatti@unipv.it.</nlm:affiliation>
</affiliation>
<affiliation>
<nlm:affiliation>Department of Internal Medicine and Therapeutics, University of Pavia, Pavia, Italy.</nlm:affiliation>
</affiliation>
</author>
<author>
<name sortKey="De Stefano, Ludovico" sort="De Stefano, Ludovico" uniqKey="De Stefano L" first="Ludovico" last="De Stefano">Ludovico De Stefano</name>
<affiliation>
<nlm:affiliation>Division of Rheumatology, IRCCS Policlinico San Matteo Foundation, Pavia, Italy.</nlm:affiliation>
</affiliation>
<affiliation>
<nlm:affiliation>Department of Internal Medicine and Therapeutics, University of Pavia, Pavia, Italy.</nlm:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Bobbio Pallavicini, Francesca" sort="Bobbio Pallavicini, Francesca" uniqKey="Bobbio Pallavicini F" first="Francesca" last="Bobbio-Pallavicini">Francesca Bobbio-Pallavicini</name>
<affiliation>
<nlm:affiliation>Division of Rheumatology, IRCCS Policlinico San Matteo Foundation, Pavia, Italy.</nlm:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Montecucco, Carlomaurizio" sort="Montecucco, Carlomaurizio" uniqKey="Montecucco C" first="Carlomaurizio" last="Montecucco">Carlomaurizio Montecucco</name>
<affiliation>
<nlm:affiliation>Division of Rheumatology, IRCCS Policlinico San Matteo Foundation, Pavia, Italy.</nlm:affiliation>
</affiliation>
<affiliation>
<nlm:affiliation>Department of Internal Medicine and Therapeutics, University of Pavia, Pavia, Italy.</nlm:affiliation>
</affiliation>
</author>
</analytic>
<series>
<title level="j">RMD open</title>
<idno type="eISSN">2056-5933</idno>
<imprint>
<date when="2020" type="published">2020</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc>
<textClass>
<keywords scheme="KwdEn" xml:lang="en">
<term>Antirheumatic Agents (pharmacology)</term>
<term>Antirheumatic Agents (therapeutic use)</term>
<term>Betacoronavirus (drug effects)</term>
<term>COVID-19 (MeSH)</term>
<term>Coronavirus Infections (prevention & control)</term>
<term>Humans (MeSH)</term>
<term>Hydroxychloroquine (pharmacology)</term>
<term>Hydroxychloroquine (therapeutic use)</term>
<term>Pandemics (prevention & control)</term>
<term>Pneumonia, Viral (prevention & control)</term>
<term>Rheumatologists (MeSH)</term>
<term>SARS-CoV-2 (MeSH)</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="pharmacology" xml:lang="en">
<term>Antirheumatic Agents</term>
<term>Hydroxychloroquine</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="therapeutic use" xml:lang="en">
<term>Antirheumatic Agents</term>
<term>Hydroxychloroquine</term>
</keywords>
<keywords scheme="MESH" qualifier="drug effects" xml:lang="en">
<term>Betacoronavirus</term>
</keywords>
<keywords scheme="MESH" qualifier="prevention & control" xml:lang="en">
<term>Coronavirus Infections</term>
<term>Pandemics</term>
<term>Pneumonia, Viral</term>
</keywords>
<keywords scheme="MESH" xml:lang="en">
<term>COVID-19</term>
<term>Humans</term>
<term>Rheumatologists</term>
<term>SARS-CoV-2</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
</TEI>
<pubmed>
<MedlineCitation Status="MEDLINE" Owner="NLM">
<PMID Version="1">33087414</PMID>
<DateCompleted>
<Year>2020</Year>
<Month>10</Month>
<Day>30</Day>
</DateCompleted>
<DateRevised>
<Year>2020</Year>
<Month>12</Month>
<Day>18</Day>
</DateRevised>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Electronic">2056-5933</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>6</Volume>
<Issue>3</Issue>
<PubDate>
<Year>2020</Year>
<Month>10</Month>
</PubDate>
</JournalIssue>
<Title>RMD open</Title>
<ISOAbbreviation>RMD Open</ISOAbbreviation>
</Journal>
<ArticleTitle>Controversies over hydroxychloroquine in the prevention of SARS-CoV-2 infection put rheumatologists on the frontline.</ArticleTitle>
<ELocationID EIdType="pii" ValidYN="Y">e001323</ELocationID>
<ELocationID EIdType="doi" ValidYN="Y">10.1136/rmdopen-2020-001323</ELocationID>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Bugatti</LastName>
<ForeName>Serena</ForeName>
<Initials>S</Initials>
<Identifier Source="ORCID">0000-0002-5396-7077</Identifier>
<AffiliationInfo>
<Affiliation>Division of Rheumatology, IRCCS Policlinico San Matteo Foundation, Pavia, Italy serena.bugatti@unipv.it.</Affiliation>
</AffiliationInfo>
<AffiliationInfo>
<Affiliation>Department of Internal Medicine and Therapeutics, University of Pavia, Pavia, Italy.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>De Stefano</LastName>
<ForeName>Ludovico</ForeName>
<Initials>L</Initials>
<AffiliationInfo>
<Affiliation>Division of Rheumatology, IRCCS Policlinico San Matteo Foundation, Pavia, Italy.</Affiliation>
</AffiliationInfo>
<AffiliationInfo>
<Affiliation>Department of Internal Medicine and Therapeutics, University of Pavia, Pavia, Italy.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Bobbio-Pallavicini</LastName>
<ForeName>Francesca</ForeName>
<Initials>F</Initials>
<AffiliationInfo>
<Affiliation>Division of Rheumatology, IRCCS Policlinico San Matteo Foundation, Pavia, Italy.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Montecucco</LastName>
<ForeName>Carlomaurizio</ForeName>
<Initials>C</Initials>
<AffiliationInfo>
<Affiliation>Division of Rheumatology, IRCCS Policlinico San Matteo Foundation, Pavia, Italy.</Affiliation>
</AffiliationInfo>
<AffiliationInfo>
<Affiliation>Department of Internal Medicine and Therapeutics, University of Pavia, Pavia, Italy.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>England</Country>
<MedlineTA>RMD Open</MedlineTA>
<NlmUniqueID>101662038</NlmUniqueID>
<ISSNLinking>2056-5933</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D018501">Antirheumatic Agents</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>4QWG6N8QKH</RegistryNumber>
<NameOfSubstance UI="D006886">Hydroxychloroquine</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName UI="D018501" MajorTopicYN="N">Antirheumatic Agents</DescriptorName>
<QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName>
<QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D000073640" MajorTopicYN="N">Betacoronavirus</DescriptorName>
<QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D000086382" MajorTopicYN="N">COVID-19</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D018352" MajorTopicYN="N">Coronavirus Infections</DescriptorName>
<QualifierName UI="Q000517" MajorTopicYN="Y">prevention & control</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D006886" MajorTopicYN="N">Hydroxychloroquine</DescriptorName>
<QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName>
<QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D058873" MajorTopicYN="N">Pandemics</DescriptorName>
<QualifierName UI="Q000517" MajorTopicYN="Y">prevention & control</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D011024" MajorTopicYN="N">Pneumonia, Viral</DescriptorName>
<QualifierName UI="Q000517" MajorTopicYN="Y">prevention & control</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D000072140" MajorTopicYN="Y">Rheumatologists</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName>
</MeshHeading>
</MeshHeadingList>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="Y">Arthritis</Keyword>
<Keyword MajorTopicYN="Y">Hydroxychloroquine</Keyword>
<Keyword MajorTopicYN="Y">Lupus Erythematosus</Keyword>
<Keyword MajorTopicYN="Y">Rheumatoid</Keyword>
<Keyword MajorTopicYN="Y">Systemic</Keyword>
</KeywordList>
<CoiStatement>Competing interests: None declared.</CoiStatement>
</MedlineCitation>
<PubmedData>
<History>
<PubMedPubDate PubStatus="received">
<Year>2020</Year>
<Month>05</Month>
<Day>13</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="revised">
<Year>2020</Year>
<Month>08</Month>
<Day>17</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="accepted">
<Year>2020</Year>
<Month>10</Month>
<Day>07</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="entrez">
<Year>2020</Year>
<Month>10</Month>
<Day>22</Day>
<Hour>5</Hour>
<Minute>28</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="pubmed">
<Year>2020</Year>
<Month>10</Month>
<Day>23</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline">
<Year>2020</Year>
<Month>10</Month>
<Day>31</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>ppublish</PublicationStatus>
<ArticleIdList>
<ArticleId IdType="pubmed">33087414</ArticleId>
<ArticleId IdType="pii">rmdopen-2020-001323</ArticleId>
<ArticleId IdType="doi">10.1136/rmdopen-2020-001323</ArticleId>
<ArticleId IdType="pmc">PMC7722363</ArticleId>
</ArticleIdList>
<ReferenceList>
<Reference>
<Citation>Arthritis Care Res (Hoboken). 2020 Jan;72(1):36-40</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">30629341</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>BMJ. 2020 May 14;369:m1849</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">32409561</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Ann Rheum Dis. 2020 Oct;79(10):1386-1388</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">32381561</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Biosci Trends. 2020 Mar 16;14(1):72-73</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">32074550</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Open Forum Infect Dis. 2020 Oct 19;7(11):ofaa500</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">33204764</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Sci Transl Med. 2020 Apr 29;12(541):</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">32253226</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>JAMA Netw Open. 2020 Apr 24;3(4):e208857</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">32330277</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Lancet. 2020 May 22;:</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">32450107</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Ann Rheum Dis. 2020 Jun;79(6):837-839</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">32332072</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Infect. 2020 Jun;80(6):607-613</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">32283152</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Nature. 2020 Sep;585(7826):584-587</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">32698191</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Ann Rheum Dis. 2010 Jan;69(1):20-8</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">19103632</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Rheumatology (Oxford). 2018 Jan 1;57(1):120-124</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">29045759</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>N Engl J Med. 2020 Nov 19;383(21):2041-2052</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">32706953</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Ann Rheum Dis. 2020 Jun;79(6):e62</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">32327429</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Front Microbiol. 2020 Jul 10;11:1704</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">32754147</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>CMAJ. 2020 Apr 27;192(17):E450-E453</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">32269021</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Clin Infect Dis. 2020 Jul 28;71(15):732-739</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">32150618</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Ann Intern Med. 2020 Oct 20;173(8):623-631</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">32673060</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>N Engl J Med. 2020 Aug 6;383(6):517-525</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">32492293</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Ann Rheum Dis. 2019 Jun;78(6):736-745</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">30926722</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Am J Hematol. 2020 Jul;95(7):834-847</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">32282949</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Nat Rev Rheumatol. 2020 Mar;16(3):155-166</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">32034323</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Ann Rheum Dis. 2020 Aug 5;:</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">32759263</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Ann Rheum Dis. 2020 Oct;79(10):1382-1383</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">32398281</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Cell Discov. 2020 Mar 18;6:16</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">32194981</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Clin Pharmacol Ther. 2020 Oct;108(4):766-769</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">32344449</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Br J Clin Pharmacol. 1989 Jun;27(6):771-9</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">2757893</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>N Engl J Med. 2020 Aug 6;383(6):585-586</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">32492298</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Clin Immunol. 2020 Jun;215:108410</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">32276140</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Int J Antimicrob Agents. 2020 Jul;56(1):105949</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">32205204</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Ann Rheum Dis. 2009 Jul;68(7):1100-4</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">19060002</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
</PubmedData>
</pubmed>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/CovidChloroV1/Data/Main/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000973 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/Main/Corpus/biblio.hfd -nk 000973 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    CovidChloroV1
   |flux=    Main
   |étape=   Corpus
   |type=    RBID
   |clé=     pubmed:33087414
   |texte=   Controversies over hydroxychloroquine in the prevention of SARS-CoV-2 infection put rheumatologists on the frontline.
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Corpus/RBID.i   -Sk "pubmed:33087414" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Corpus/biblio.hfd   \
       | NlmPubMed2Wicri -a CovidChloroV1 

Wicri

This area was generated with Dilib version V0.6.38.
Data generation: Sat May 22 17:02:32 2021. Site generation: Sat May 22 17:06:52 2021